Organised by Government of Australia and the Civil Society Task Force David Laffan, Assistant Secretary, Alcohol, Tobacco and Other Drugs Branch, Australian Department of Health Distinguished delegates, ladies and gentleman, I am honoured to be co-chairing this important event with the Civil Society Task Force on Drugs. This event in itself is an example of …
Australia
Special Event – Increasing Access to Controlled Medicines: Addressing the Global Disparity in Pain Relief
H.E. Ghislain D’hoop, Belgian Ambassador (Moderating): The global disparity in pain relief is unacceptable to my country, and we provide resources to UNODC and INCB to address this challenge. Yury Fedotov, UNODC Executive Director: The number on this issue speak for themselves. Pain management is a human rights concern, and palliative care is essential. Controlled substances are …
Committee of the Whole (Thursday morning). L9: Promoting measures to prevent transmission of HIV for women who use drugs, including by improving access to post-exposure prophylaxis
Chair: We now move to L9. I give the floor to Brazil who has led on the resolution and informal consultations. Brazil: We had 4 informals on this resolution. This has been quite constructive, we have agreed on a good number of paragraphs, and on many paragraphs we have opened language that was similar to …
Committee of the Whole (Thursday morning). L4. Promoting measures to prevent and treat viral hepatitis C among people who use drugs
Chair: Happy new year to those who celebrate Norway: Thank you everyone for time yesterday – 3 outstanding PPs and title left. Let’s first agree to paragraphs agreed in informals. PPs on 2019 Ministerial Declaration USA: Thank you Norway – combine PPs on Min Dec statements. Belgium: Amendment for last line – add ‘continue to …
Committee of the Whole, Wednesday morning / Thursday afternoon (L7. Advancing effective and innovative approaches, through national, regional, and international action, to address the multifaceted challenges posed by synthetic drugs, particularly synthetic opioids
USA: Thank you chair, we have had three sessions of informals and believe we have completed a review of the preamble so should be able to get through that but may need time or the operative paragraphs. Chair: We will now move through L7, is there any comments? Title approved. PP1 Australia: originally this pp …
Committee of the Whole, Monday morning (L5.– Enhancing forensic detection capability for synthetic drugs through increasing international collaboration)
Chair: Today we will start on L5, moving to L7 then, L8. Australia: Through the informals L6 has reached complete consensus. Chair: Is the room ready to approve the paragraph as it is? PP1 Chair: Approved, and can we approve the final preamble paragraph? Final PP Chair: Passed.